Several states are resuming Johnson and Johnson COVID-19 vaccinations after getting the go-ahead from federal health officials. The CDC and the FDA signed off on lifting the pause when an advisory panel said the benefits outweigh the risks.
Reports of rare blood clots in women who got the single-dose vaccine is what prompted the less than two week pause. Although use of the shot is starting up again, a new poll shows many Americans aren’t so sure about it.
The results of a survey from ABC News/Washington Post found 46-percent of people say they believe the J&J vaccine is very or somewhat safe.